Stay updated on Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website’s footer revision marker changed from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-21T16:51:52.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The record displays details for a completed non-small cell lung cancer study evaluating viagenpumatucel-L in combination with other therapies. It includes participant eligibility, treatment plans, outcome measures, study dates, and related documents.
    Difference
    65%
    Check dated 2026-11-07T16:49:33.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the study record remains unavailable behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T17:02:22.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-24T22:33:48.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T22:40:31.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-10T22:29:02.000Z thumbnail image

Stay in the know with updates to Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.